{"id":"W2075141373","doi":"10.1200/jco.2008.17.1561","title":"Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Vincristine; Rituximab; Internal medicine; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; International Prognostic Index; Gastroenterology; Chemotherapy; Surgery; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007480532,0.000251544,0.00330803,0.0001108603,0.0000421226,0.0000101331,0.0002707765,0.0002552254,0.00001096292],"category_scores_gemma":[0.01092843,0.0001267055,0.0005383592,0.0002198894,0.000396481,0.0001100045,0.0001441849,0.0004126062,0.000001148925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002238492,"about_ca_system_score_gemma":0.0009507101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004991571,"about_ca_topic_score_gemma":0.0001239168,"domain_scores_codex":[0.993223,0.001351863,0.00412324,0.0003527523,0.0006327273,0.0003164314],"domain_scores_gemma":[0.9928412,0.003106216,0.002855743,0.0004812429,0.0004412866,0.0002743308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5808049,0.04590476,0.09241938,0.00002125177,0.0003318076,0.001613904,0.0004621717,0.000003303965,0.00001280467,0.00002128067,0.0003688525,0.2780356],"study_design_scores_gemma":[0.5212825,0.01361794,0.4631668,0.000349992,0.0003952656,0.0001179266,0.0001298334,0.00003442746,0.00007257643,0.0002385304,0.0005266153,0.00006762038],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854863,0.002005327,0.000009793011,0.009085357,0.0006833783,0.002171104,0.0000149009,0.00000783067,0.000535995],"genre_scores_gemma":[0.996227,0.001155901,0.001553449,0.0006702273,0.0002202521,0.00008305166,0.000001679744,0.0000125567,0.00007583008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3707474,"threshold_uncertainty_score":0.997403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02955410953605098,"score_gpt":0.4113715754994215,"score_spread":0.3818174659633706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}